Dasatinib Modulates Invasive and Migratory Properties of Canine Osteosarcoma and has Therapeutic Potential in Affected Dogs
BACKGROUND: This investigation sought to elucidate the relationship between hepatocyte growth factor (HGF)–induced metastatic behavior and the tyrosine kinase inhibitors (TKIs) crizotinib and dasatinib in canine osteosarcoma (OS). Preliminary evidence of an apparent clinical benefit from adjuvant th...
Main Authors: | Kevin Marley, Justine Gullaba, Bernard Seguin, Howard B. Gelberg, Stuart C. Helfand |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-08-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523315000224 |
Similar Items
-
The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma <it>in vitro</it>
by: Marley Kevin, et al.
Published: (2013-01-01) -
Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
by: Olaf Beck, et al.
Published: (2020-03-01) -
Canine Soft Tissue Sarcomas: Can Being a Dog’s Best Friend Help a Child?
by: Bernard Séguin
Published: (2017-11-01) -
Cutaneous and subcutaneous metastasis of appendicular osteosarcoma in dogs: 20 cases
by: Cyril Parachini‐Winter, et al.
Published: (2019-09-01) -
Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
by: Benoît Thibault, et al.
Published: (2017-04-01)